| |
| |
|
| Insider
Information: |
Oki Mark K |
| Relationship: |
Chief Financial Officer |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
251,638 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$553,238 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
251,638 |
|
|
| Total
Value |
$553,238 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
SVP, CFO and Sec |
2013-03-29 |
49,538 |
|
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
SVP, CFO, CAO |
2019-11-14 |
12,100 |
2018-11-06 |
0 |
Premium* |
|
|
AYTU BIOSCIENCE, INC |
AYTU |
Chief Financial Officer |
2022-11-18 |
190,000 |
2022-01-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2022-11-18 |
4/A |
B |
$0.23 |
$20,700 |
D/D |
90,000 |
190,000 |
2.74 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• • – |
2022-11-18 |
4 |
A |
$0.23 |
$20,700 |
D/D |
90,000 |
190,000 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2022-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
SVP, CFO, CAO |
• – – |
2019-11-14 |
4 |
A |
$2.38 |
$1,666 |
D/D |
700 |
12,100 |
0 |
- |
|
| VVUS |
Vivus Inc |
Chief Financial Officer & CAO |
• – – |
2018-11-14 |
4 |
A |
$2.71 |
$1,897 |
D/D |
700 |
10,700 |
0 |
- |
|
| VVUS |
Vivus Inc |
Chief Financial Officer & CAO |
• – – |
2018-11-06 |
4 |
B |
$4.07 |
$40,700 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO and Sec |
• – – |
2013-03-29 |
4 |
A |
$4.42 |
$193,375 |
D/D |
43,750 |
49,538 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO and Sec |
• – – |
2012-08-27 |
4 |
AS |
$4.14 |
$41,364 |
D/D |
(10,000) |
3,788 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
VP Fin Controller PAO PFO Sec |
• – – |
2012-06-06 |
4 |
AS |
$0.34 |
$10,776 |
D/D |
(31,873) |
137,896 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
VP Fin Controller PAO PFO Sec |
• – – |
2012-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
169,769 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
VP Fin Controller PAO PFO Sec |
• – – |
2012-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
31,873 |
69,769 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
VP Fin, Controller & PAOOffice |
• – – |
2010-05-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
31,168 |
|
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
VP Fin, Controller & PAOOffice |
• – – |
2010-05-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,085 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
